Publications
2 shownOverall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer
Purpose Programmed death 1 is an immune checkpoint that suppresses antitumor immunity. Nivolumab, a fully human immunoglobulin G4 programmed death 1 immune checkpoint inhibitor ...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 3,125
- Institution
- The University of Texas Southwestern Medical Center
External Links
Identifiers
- ORCID
- 0000-0003-3002-1921
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.